Whilst berberine may influence glucose metabolism through various cellular pathwaysprimarily by activating AMP-activated protein kinase (AMPK)the evidence for direct GLP-1 receptor activation remains limited and indirect
Kiley has a passion for weight loss management, injectables such as neurotoxin and filler, NAD+ therapy, IV therapy, and sclerotherapy to support overall health and wellness for our patients
Zepbound is a newer drug with less clinical evidence available, while semaglutide GLP-1 remains a tried-and-true alternative because of its track record for weight loss success
However, if data are good, iBio will be significantly validated and may double from current levels
Having more options available to patients is a good thing, says Daniel Drucker, an endocrinologist at the University of Toronto whose research paved the way for GLP-1 drugs but who was not involved in the new studies